Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension

Thrombosis Research

Volumn 126, Issue 6, 2010, Pages

  Tournier, Agnès ^a,b   Wahl, Denis ^a,b,c   Chaouat, Ari ^b,c   Max, Jean Pierre ^a,b   Regnault, Véronique ^a,b,c   Lecompte, Thomas ^a,b,c   Chabot, François ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Coagulation; Endothelium dysfunction; Haemostasis; Pulmonary circulation

Indexed keywords

ACTIVATED PROTEIN C; D DIMER; THROMBIN; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CALIBRATED AUTOMATED THROMBOGRAPHY; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; IN VITRO STUDY; LUNG CIRCULATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; THROMBOELASTOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOMATION; BLOOD COAGULATION TESTS; CALIBRATION; CASE-CONTROL STUDIES; ENDOTHELIUM; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY ARTERY; THROMBOPHILIA; YOUNG ADULT;

EID: 78649720720     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.08.020     Document Type: Article

References (43)

1. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, and C.P. Denton Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
2. M. Humbert, N.W. Morrell, S.L. Archer, K.R. Stenmark, M.R. MacLean, and I.M. Lang Cellular and molecular pathobiology of pulmonary arterial hypertension J Am Coll Cardiol 43 2004 13S 24S (Pubitemid 38759713)
3. N. Galie, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J 34 2009 1219 1263
4. V. Fuster, P.M. Steele, W.D. Edwards, B.J. Gersh, M.D. McGoon, and R.L. Frye Primary pulmonary hypertension: natural history and the importance of thrombosis Circulation 70 1984 580 587
5. P. Herve, M. Humbert, O. Sitbon, F. Parent, H. Nunes, and C. Legal Pathobiology of pulmonary hypertension. The role of platelets and thrombosis Clin Chest Med 22 2001 451 458
6. M.M. Hoeper, M. Sosada, and H. Fabel Plasma coagulation profiles in patients with severe primary pulmonary hypertension Eur Respir J 12 1998 1446 1449
7. C.H. Welsh, K.L. Hassell, D.B. Badesch, D.C. Kressin, and R.A. Marlar Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension Chest 110 1996 710 717
8. A.A. Lopes, N.Y. Maeda, and S.P. Bydlowski Abnormalities in circulating von Willebrand factor and survival in pulmonary hypertension Am J Med 105 1998 21 26
9. A.A. Lopes, N.Y. Maeda, R.C. Goncalves, and S.P. Bydlowski Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension Am Heart J 139 2000 618 623
10. A.A. Lopes, N.Y. Maeda, V.D. Aiello, M. Ebaid, and S.P. Bydlowski Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension Chest 104 1993 1455 1460
11. U.M. Vischer von Willebrand factor, endothelial dysfunction, and cardiovascular disease J Thromb Haemost 4 2006 1186 1193
12. P.R. Eisenberg, C. Lucore, L. Kaufman, B.E. Sobel, A.S. Jaffe, and S. Rich Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension Circulation 82 1990 841 847
13. L.L. Schulman, B.A. Grossman, and J. Owen Platelet activation and fibrinopeptide formation in pulmonary hypertension Chest 104 1993 1690 1693
14. G. Christ, S. Graf, R. Huber-Beckmann, G. Zorn, I. Lang, and M. Kneussi Impairment of the plasmin activation system in primary pulmonary hypertension: evidence for gender differences Thromb Haemost 86 2001 557 562
15. A.A. Lopes, L.H. Caramuru, and N.Y. Maeda Endothelial dysfunction associated with chronic intravascular coagulation in secondary pulmonary hypertension Clin Appl Thromb Haemost 8 2002 353 358
16. D. Shitrit, D. Bendayan, A. Bar-Gil-Shitrit, M. Huerta, B. Rudensky, and G. Fink Significance of a plasma D-dimer test in patients with primary pulmonary hypertension Chest 122 2002 1674 1678 (Pubitemid 35366081)
17. P. Cacoub, M. Karmochkine, R. Dorent, P. Nataf, J.C. Piette, and P. Godeau Plasma levels of thrombomodulin in pulmonary hypertension Am J Med 101 1996 160 164
18. G. Cella, F. Bellotto, F. Tona, A. Sbarai, G. Mazzaro, and G. Motta Plasma markers of endothelial dysfunction in pulmonary hypertension Chest 120 2001 1226 1230 (Pubitemid 32960098)
19. M.T. Collados, B. Velazquez, J.R. Borbolla, J. Sandoval, F. Masso, and L.F. Montano Endothelin-1 and functional tissue factor: a possible relationship with severity in primary pulmonary hypertension Heart Vessels 18 2003 12 17
20. H. Weiler, and B.H. Isermann Thrombomodulin J Thromb Haemost 1 2003 1515 1524
21. J.T. Crawley, and D.A. Lane The haemostatic role of tissue factor pathway inhibitor Arterioscler Thromb Vasc Biol 28 2008 233 242
22. H.C. Hemker, P. Giesen, R. AlDieri, V. Regnault, E. de Smed, and R. Wagenvoord The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability Pathophysiol Haemost Thromb 32 2002 249 253
23. K. Devreese, K. Peerlinck, J. Arnout, and M.F. Hoylaerts Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography Thromb Haemost 101 2009 185 196
24. V. Regnault, F. Boehlen, H. Ozsahin, D. Wahl, P.G. de Groot, and T. Lecompte Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation J Thromb Haemost 3 2005 1243 1249
25. F. Chabot, F. Schrijen, F. Poincelot, and J.M. Polu Interpretation of high wedge pressure on exercise in patients with chronic obstructive pulmonary disease Cardiology 95 2001 139 145
26. H.C. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. de Smedt, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
27. V. Regnault, E. De Maistre, C. Geschier, M.E. Briquel, E. André, and J.F. Stoltz A new fast one-step immunopreparation for activated protein C Thromb Haemost 73 1995 1365
28. V. Regnault, S. Beguin, and T. Lecompte Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability Pathophysiol Haemost Thromb 33 2003 23 29
29. A.K. Ohlin, K. Larsson, and M. Hansson Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma J Thromb Haemost 3 2005 976 982
30. A.E. Dahm, T.O. Andersen, F. Rosendaal, and P.M. Sandset A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI) J Thromb Haemost 3 2005 651 658
31. M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, and V. Gressin Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 2006 1023 1030
32. Y. Dargaud, R. Luddington, E. Gray, C. Negrier, T. Lecompte, and S. Petros Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study Br J Haematol 139 2007 303 309
33. Y. Dargaud, R. Luddington, E. Gray, T. Lecompte, T. Siegemund, and T. Baglin Standardisation of thrombin generation test-which reference plasma for TGT? An international multicentre study Thromb Res 125 2010 353 356
34. M. Trossaert, V. Regnault, M. Sigaud, P. Boisseau, E. Fressinaud, and T. Lecompte Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype J Thromb Haemost 6 2008 486 493
35. B. Bakouboula, O. Morel, A. Faure, F. Zobairi, L. Jesel, and A. Trinh Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension Am J Respir Crit Care Med 177 2008 536 543
36. T. Lecompte, D. Wahl, C. Perret-Guillaume, H.C. Hemker, P. Lacolley, and V. Regnault Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk Haematologica 92 2007 714 715
37. V. Regnault, H.C. Hemker, D. Wahl, and T. Lecompte Phenotyping the haemostatic system by thrombography-potential for the estimation of thrombotic risk Thromb Res 114 2004 539 545
38. H. Ishii, and P.W. Majerus Thrombomodulin is present in human plasma and urine J Clin Invest 76 1985 2178 2181
39. F. Sakamaki, S. Kyotani, N. Nagaya, N. Sato, H. Oya, and T. Satoh Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy Circulation 102 2000 2720 2725
40. N.A. Zakai, P.L. Lutsey, A.R. Folsom, S.R. Heckbert, and M. Cushman Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology Thromb Haemost 104 2010 207 212
41. E.F. Grabowski, A.J. Reininger, P.G. Petteruti, O. Tsukurov, and R.W. Orkin Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor Arterioscler Thromb Vasc Biol 21 2001 157 162
42. M. Miniati, C. Fiorillo, M. Becatti, S. Monti, M. Bottai, and C. Marini Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic Am J Respir Crit Care Med 181 2010 992 996
43. S. Rich, E. Kaufmann, and P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76 81